{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:49:11Z","timestamp":1791143351594,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T00:00:00Z","timestamp":1265673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s12032-010-9443-1","type":"journal-article","created":{"date-parts":[[2010,2,8]],"date-time":"2010-02-08T15:41:14Z","timestamp":1265643674000},"page":"315-321","source":"Crossref","is-referenced-by-count":54,"title":["Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"28","author":[{"given":"Shu-zhen","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-qi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,9]]},"reference":[{"key":"9443_CR1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/s-2005-871989","volume":"26","author":"T Evans","year":"2005","unstructured":"Evans T. Chemotherapy in advanced non-small cell lung cancer. Semin Respir Crit Care Med. 2005;26:304\u201313. doi: 10.1055\/s-2005-871989 .","journal-title":"Semin Respir Crit Care Med"},{"key":"9443_CR2","first-page":"4899","volume":"62","author":"T Furuta","year":"2002","unstructured":"Furuta T, Ueda T, Aune G, et al. Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells. Cancer Res. 2002;62:4899\u2013902.","journal-title":"Cancer Res"},{"key":"9443_CR3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","volume":"355","author":"KA Olaussen","year":"2006","unstructured":"Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med. 2006;355:983\u201391.","journal-title":"N Engl J Med"},{"key":"9443_CR4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature01746","volume":"424","author":"J Chen","year":"2003","unstructured":"Chen J, Larochelle S, Li X, et al. Xpd\/Ercc2 regulates CAK activity and mitotic progression. Nature. 2003;424:228\u201332. doi: 10.1038\/nature01746 .","journal-title":"Nature"},{"key":"9443_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.seminoncol.2003.12.011","volume":"31","author":"R Rosell","year":"2004","unstructured":"Rosell R, Taron M, Ariza A, et al. Molecular predictors of response to chemotherapy in lung cancer. Semin Oncol. 2004;31:20\u20137. doi: 10.1053\/j.seminoncol.2003.12.011 .","journal-title":"Semin Oncol"},{"key":"9443_CR6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJMp068308","volume":"356","author":"AF Gazdar","year":"2007","unstructured":"Gazdar AF. DNA repair and survival in lung cancer\u2014the two faces of Janus. N Engl J Med. 2007;356:771\u20133.","journal-title":"N Engl J Med"},{"key":"9443_CR7","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/nm1491","volume":"12","author":"A Potti","year":"2006","unstructured":"Potti A, Dressman HK, Bild A, et al. Genomic signatures to guide the use of chemotherapeutics. Nat Med. 2006;12:1294\u2013300. doi: 10.1038\/nm1491 .","journal-title":"Nat Med"},{"key":"9443_CR8","first-page":"719","volume":"22","author":"NH Mantel","year":"1959","unstructured":"Mantel NH. Statistical aspect of the analysis of data from retrospective studies of disease. Natl Cancer Inst. 1959;22:719\u201348. doi: 10.1016\/0021-9681(79)90031-6 .","journal-title":"Natl Cancer Inst"},{"key":"9443_CR9","doi-asserted-by":"crossref","unstructured":"Zhou C, Ren S, Zhou S, et al. Genotyping single-nucleotide polymorphisms (SNPs) in ERCC1 and XRCC3 genes for efficacy prediction in chemotherapy of non-small cell lung cancer (NSCLC). J Clin Oncol. 2008;26.","DOI":"10.1200\/jco.2008.26.15_suppl.8098"},{"key":"9443_CR10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3816\/CLC.2003.n.004","volume":"4","author":"C Camps","year":"2003","unstructured":"Camps C, Sarries C, Roig B, et al. Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine\/cisplatin-treated advanced non-small-cell lung cancer patients. Clin Lung Cancer. 2003;4:237\u201341. doi: 10.3816\/CLC.2003.n.004 .","journal-title":"Clin Lung Cancer"},{"key":"9443_CR11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdh319","volume":"15","author":"D Isla","year":"2004","unstructured":"Isla D, Sarries C, Rosell R, et al. Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer. Ann Oncol. 2004;15:1194\u2013203. doi: 10.1093\/annonc\/mdh319 .","journal-title":"Ann Oncol"},{"key":"9443_CR12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2003.11.019","volume":"44","author":"JS Ryu","year":"2004","unstructured":"Ryu JS, Hong YC, Han HS, et al. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Lung Cancer. 2004;44:311\u20136. doi: 10.1016\/j.lungcan.2003.11.019 .","journal-title":"Lung Cancer"},{"key":"9443_CR13","first-page":"196","volume":"28","author":"P Yuan","year":"2006","unstructured":"Yuan P, Miao XP, Zhang XM, et al. XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer. Zhonghua Zhong Liu Za Zhi. 2006;28:196\u20139.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"9443_CR14","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/cncr.21885","volume":"106","author":"R Booton","year":"2006","unstructured":"Booton R, Ward T, Heighway J, et al. Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer. Cancer. 2006;106:2421\u20137. doi: 10.1002\/cncr.21885 .","journal-title":"Cancer"},{"key":"9443_CR15","unstructured":"Song DG, Liu J, Wang JH, et al. XRCC1 and XPD genetic polymorphisms predict clinical responses to platinum-based chemotherapy in advanced non-small cell lung cancer. Chin J Gerontol. 2007;1684-86."},{"key":"9443_CR16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.lungcan.2006.12.002","volume":"56","author":"D Su","year":"2007","unstructured":"Su D, Ma S, Liu P, et al. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer. 2007;56:281\u20138. doi: 10.1016\/j.lungcan.2006.12.002 .","journal-title":"Lung Cancer"},{"key":"9443_CR17","first-page":"306","volume":"22","author":"H Fan","year":"2008","unstructured":"Fan H, Jin GF, Shen HB. Relationship of XRCC1 and XPD gene polymorphisms with chemosensitivity to platinum-based chemotherapy in advanced non-small cell lung cancer. Pract Geriatr. 2008;22:306\u201314.","journal-title":"Pract Geriatr"},{"key":"9443_CR18","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1158\/1078-0432.CCR-07-1364","volume":"14","author":"C Tibaldi","year":"2008","unstructured":"Tibaldi C, Giovannetti E, Vasile E, et al. Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine\/cisplatin-treated advanced non-small cell lung cancer patients. Clin Cancer Res. 2008;14:1797\u2013803. doi: 10.1158\/1078-0432.CCR-07-1364 .","journal-title":"Clin Cancer Res"},{"key":"9443_CR19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3816\/CLC.2009.n.015","volume":"10","author":"A Kalikaki","year":"2009","unstructured":"Kalikaki A, Kanaki M, Vassalou H, et al. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer. 2009;10:118\u201323. doi: 10.3816\/CLC.2009.n.015 .","journal-title":"Clin Lung Cancer"},{"key":"9443_CR20","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2008.20.8793","volume":"27","author":"DR Gandara","year":"2009","unstructured":"Gandara DR, Kawaguchi T, Crowley J, et al. Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics. J Clin Oncol. 2009;27:3540\u20136.","journal-title":"J Clin Oncol"},{"key":"9443_CR21","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1200\/JCO.2004.04.900","volume":"22","author":"HJ Lenz","year":"2004","unstructured":"Lenz HJ. The use and development of germline polymorphisms in clinical oncology. J Clin Oncol. 2004;22:2519\u201321. doi: 10.1200\/JCO.2004.04.900 .","journal-title":"J Clin Oncol"},{"key":"9443_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","volume":"24","author":"E Reed","year":"2008","unstructured":"Reed E. Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treat Rev. 2008;24:331\u201344.","journal-title":"Cancer Treat Rev"},{"key":"9443_CR23","first-page":"1513","volume":"11","author":"EL Goode","year":"2002","unstructured":"Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1513\u201330.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9443_CR24","doi-asserted-by":"crossref","unstructured":"Yu JJ, Mu C, Lee KB, Okamoto A, et al. A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues. Mutat Res. 2007; 382:13\u201320. doi: 10.1016\/S1383-5726(97)00004-6 .","DOI":"10.1016\/S1383-5726(97)00004-6"},{"key":"9443_CR25","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1093\/emboj\/16.21.6559","volume":"16","author":"E Evans","year":"1997","unstructured":"Evans E, Moggs JG, Hwang JR, et al. Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J. 1997;16:6559\u201373. doi: 10.1093\/emboj\/16.21.6559 .","journal-title":"EMBO J"},{"key":"9443_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7150\/ijms.4.59","volume":"4","author":"C Kiyohara","year":"2007","unstructured":"Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci. 2007;4:59\u201371.","journal-title":"Int J Med Sci"},{"key":"9443_CR27","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","volume":"22","author":"S Gurubhagavatula","year":"2004","unstructured":"Gurubhagavatula S, Liu G, Park S, et al. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol. 2004;22:2594\u2013601. doi: 10.1200\/JCO.2004.08.067 .","journal-title":"J Clin Oncol"},{"key":"9443_CR28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/jnci\/92.6.440","volume":"92","author":"Q Wei","year":"2000","unstructured":"Wei Q, Frazier ML, Levin B. DNA repair: a double-edged sword. J Natl Cancer Inst. 2000;92:440\u20131.","journal-title":"J Natl Cancer Inst"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9443-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-010-9443-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9443-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:22:44Z","timestamp":1559442164000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-010-9443-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9443"],"URL":"https:\/\/doi.org\/10.1007\/s12032-010-9443-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,9]]}}}